Cargando…
Loading, please waitCargando…
Loading, please waitMexico has quietly become one of the world's most-visited destinations for regenerative medicine. Patients from the United States, Canada, and across Mexico travel here for mesenchymal stem cell (MSC) and exosome protocols that are regulated, physician-administered, and far more accessible than equivalent cash-pay care at home. But “Mexico” is not a clinic, and the country's reputation is only as good as the specific establishment you choose. This guide explains how stem cell therapy is regulated in Mexico, why so many patients travel to Cancún specifically, which conditions are realistically evaluated, what actually drives the cost of a personalized protocol, and — most importantly — how to verify any clinic before you book.
The reasons are consistent across thousands of patients. First, access: in the United States, most allogeneic mesenchymal stem cell protocols sit inside the FDA's investigational (IND) pathway and are largely unavailable for routine clinical use, so a patient whose orthopedic surgeon offers only joint replacement, or whose neurologist offers only symptom management, simply has no domestic regenerative option. Mexico's federal health authority, COFEPRIS, permits these protocols under a defined sanitary framework. Second, cost: facility overhead, malpractice-insurance structure, and pharmaceutical supply chains cost less in Mexico, so the same standard of care is reachable for many patients who could never afford US cash-pay rates — without cutting clinical corners. Third, proximity and logistics: Cancún is under four hours' flight from most major US hubs, English is widely spoken in medical settings, and concierge support removes most of the friction of traveling for care.
None of this means “anything goes.” The same demand that built Mexico's reputation also attracts sales-driven operators, which is exactly why the back half of this guide is a verification checklist, not a sales pitch.
Yes. Stem cell therapy is legal in Mexico when it is performed by a licensed physician in an establishment authorized by COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios) — Mexico's federal sanitary authority, broadly analogous in role to the U.S. FDA. A compliant clinic operates under a verifiable Aviso de Funcionamiento (operating notice) and, for health-related advertising, an Aviso de Publicidad. Just as importantly, the laboratory that processes the cells must hold the three COFEPRIS authorizations required for human cell banking — tissue collection, tissue bank, and clinical-application licenses. “Legal in Mexico” therefore is not a loophole; it is a paper trail you are entitled to inspect.
What this means in practice: a legitimate Mexican clinic will name its regulator, give you its authorization number, and welcome verification — never market a regulatory “gap” as if the absence of oversight were a benefit. Regeneris operates under COFEPRIS Aviso de Funcionamiento No. 2323025036X00098 and Aviso de Publicidad No. 2323022002A00053, and publishes both so you can confirm them rather than take our word for it.
These six documents are the difference between a clinic and a sales room. Below, we hold ourselves to each one — with a link to the underlying proof so you can verify it independently.
This is the table the aggregator listicles don't give you, because it isn't a paid leaderboard — it's regulator-grade, clinic-agnostic, and you can apply it to us or to anyone else.
| Evaluation criterion | What a compliant clinic should show | Red flag | Why it matters |
|---|---|---|---|
| COFEPRIS federal license | A specific Aviso de Funcionamiento number, published and verifiable | “COFEPRIS-regulated” with no number; an “international zone” exemption claim | The number proves the regulator actually reviewed the establishment |
| Named physician with cédula | The treating doctor's full name and cédula profesional, verifiable at the public SEP registry | “Our medical team,” unattributed headshots, no names in writing | Informed consent and accountability require a named, licensed clinician |
| Lab quality | A laboratory holding the three cell-banking licenses; GMP/ISO clean-room; lot-specific Certificate of Analysis | “The lab is our own” with no separate accreditation or CoA | The infusion is only as safe as the lab upstream of it |
| Cell characterization & viability | Surface-marker identity (CD73/CD90/CD105+, CD34/CD45−) and post-thaw viability per ISCT criteria | No characterization disclosed; “high-dose” with no measured numbers | These are the internationally accepted minimal criteria defining an MSC product |
| Cell source disclosure | Whether cells are autologous or allogeneic, and the tissue source, with donor screening | A branded, unspecified “proprietary blend” with no biological identity | You are entitled to know the biological identity of what is infused |
| Evidence-based indications | Honest, indication-specific evidence; declines conditions outside the evidence base | One “cure-all” protocol for arthritis, autism, Alzheimer's, and anti-aging alike | No preparation has equal evidence across unrelated indications |
| Transparent, personalized quote | A written, itemized, all-inclusive quote issued after a physician evaluation | A flat price quoted over WhatsApp before any physician sees your case | A flat price quoted before evaluation is a product, not a treatment |
| Structured follow-up | A scheduled follow-up calendar with named contacts and outcomes tracking | “Call us if you have questions,” no scheduled follow-up | The biological response unfolds over weeks to months; follow-up is care, not courtesy |
Candidacy is always decided by a physician after reviewing your history, imaging, and labs — not by a sales page. We evaluate, and where the evidence supports it, treat the following. Where the evidence is thin, we say so and decline or refer.
Orthopedic & joint
Autoimmune & inflammatory
Neurological & degenerative
Metabolic, systemic & men's health
There is no single price for stem cell therapy in Mexico, and any clinic that quotes you one before a physician has reviewed your case is quoting a product, not a treatment. The real cost depends on a small number of clinical variables: the cell count and viability your indication requires, the cell source (autologous vs. allogeneic / umbilical-cord Wharton's jelly), the delivery route (localized infiltration, IV, or combined), the number of treatment sites and sessions, imaging guidance when indicated, any medically-justified adjunct therapies, and the supplying laboratory's quality and characterization cost. Because dose and preparation genuinely vary by patient and indication — a point the peer-reviewed literature makes explicitly — a responsible clinic builds the price around your case rather than around a brochure.
Patients routinely find that regenerative protocols in Mexico cost a fraction of the equivalent in the United States — not because the science is different, but because facility overhead, malpractice-insurance structure, and pharmaceutical supply chains cost less here. Lower cost should never come from lower-quality cells, an unaccredited lab, or skipped follow-up, which is exactly why you should compare written, itemized quotes line by line, not headline numbers. At Regeneris we do not publish a flat price, because a flat price is by definition not personalized — we publish exactly how the price is built, and issue your quote in writing, itemized and all-inclusive, only after a free medical evaluation.
Within Mexico, Cancún has become a natural hub for regenerative medical tourism. Its international airport is one of the busiest in Latin America, with direct flights under four hours from most major U.S. and Canadian cities; English is widely spoken in medical and hospitality settings; and the recovery environment — a calm, warm destination — is genuinely better suited to the days after an infusion than a connecting-flight marathon. Regeneris is located at Av. Tulúm SM 11 MZ 1 Lote 1 Local 207, San Francisco, 77504 Cancún, Q.R.
Aggregator listicles lead with platform-wide numbers that belong to a directory, not to any one clinic. We prefer signals you can verify directly: a published COFEPRIS authorization number (Aviso de Funcionamiento No. 2323025036X00098), physicians named with individually verifiable cédulas profesionales, a named responsable sanitario, and a multidisciplinary team you can look up one by one at cedulaprofesional.sep.gob.mx. More than 3,360 patients from Mexico, the United States, Canada, and Europe have been treated to date (as of 2026). We would rather give you four things you can check than one number you can't.
Information for educational purposes only. This guide does not constitute medical advice and does not replace evaluation by a licensed physician. Mesenchymal stem cell therapy is investigational for many indications; outcomes vary by patient, indication, and prior medical history. No cure is implied or guaranteed.
Talk to our medical team
A physician reviews your case before any quote. Your personalized quote is issued in writing, itemized and all-inclusive — never a number over WhatsApp.